Health News Releases

March 15, 09:30

PMC Group International Announces Copperhead Chemical Company Inc. Receives Northrop Grumman Strategic Excellence Award

Copperhead Chemical Company Inc., a subsidiary of PMC Group International, earned Northrop Grumman’s 2022 Strategic Excellence Award as part of their Supplier Excellence Awards. This award distinguish

March 14, 17:20

Region’s First Global Robotic MedTech Forum to Reveal Latest Advancements in Robotic Surgery

The US Society of Robotic Surgery and Crescent Healthcare (a Division of the Crescent Group of Companies) host the first Global Robotic MedTech Forum in the Middle East on 16 March 2023 in Dubai. The

March 13, 15:30

Galderma Delivers Strong FY 2022 Growth Driven by Innovation and Commercial Performance

Galderma: Galderma delivered strong performance · Galderma delivered at the top end of its 2022 revenue guidance with 13.9% year-on-year net sales growth on a constant currency basis at 3,760 M

March 10, 10:20

New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospital in Beijing ev

March 09, 08:42

Biocytogen Announces RenLite™ Licensing Agreement with Janssen

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) (HKEX: 02315), today announced the signing of a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceuti

March 08, 10:25

Clifford Hallam Healthcare Selects Rimini Consult™ Professional Services to Accelerate Business Targets Through Improved SAP System Operations

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products, and a Salesforce part

March 08, 10:10

Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist

Organon (NYSE: OGN), a global healthcare company focused on improving women’s health, today announced the launch of a new global initiative, “Her Plan is Her Power,” to accelerate progress toward addr

March 07, 17:24

MRM Health Completes Patient Recruitment in Ulcerative Colitis Study, Secures Financing and Provides Outlook for 2023

MRM Health—a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics based on its proprietary and unique CORAL® platform technology - toda

March 07, 11:40

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients

Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondic

March 06, 17:45

Dr. Jack Kolenda from Toronto and Lux Vitae Worldwide Announce That The Steriwave Nasal Decolonization Treatment Has Been Successfully Used By The Rock Band KISS Since September of 2021, To Prevent The Transmission And Spread of Covid 19

Dr. Jack Kolenda from Toronto and Lux Vitae Worldwide Are Pleased To Announce That The Steriwave Nasal Decolonization Treatment, Has Been Successfully Used By The Rock Band KISS Since September of 202

March 05, 10:10

Medidata Drives Diversity in Clinical Trials, Passing 30,000 Studies and 9 Million Participants

Known for its ground-breaking technological innovations in clinical trials, Medidata, a Dassault Systèmes company, has exceeded 30,000 clinical trials and 9 million study participants. These milestone

March 03, 13:55

AIT Worldwide Logistics Expands Global Network, Pharmaceutical Logistics Expertise to South Korea

Global freight forwarder AIT Worldwide Logistics is proud to announce its debut facility in the world‘s 10th largest economy with the opening of the company’s Seoul location, the first of several plan

March 02, 14:20

Microba Launches Next Generation Healthcare Testing

Microba Life Sciences Limited (ASX: MAP) (“Microba”), a precision microbiome company, is pleased to announce that it’s next generation testing product range, MetaXplore™ has been launched to healthcar

March 02, 14:15

Carbios Doubles Its Number of Granted Patents in Two Years for Its Proprietary Enzymatic Technologies

Regulatory News: Carbios (Euronext Growth Paris: ALCRB) (Paris:ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and texti

March 02, 11:30

Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership

Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, today announced that it has acquired a manufacturing facility in Modi’in, Israel, and certain related ass

March 02, 11:15

GE HealthCare Announces Completion of Phase I Subject Recruitment in Early Clinical Development Program for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent

GE HealthCare has today announced, at the European Congress of Radiology (ECR) in Vienna, Austria, the completion of Phase I subject recruitment in its early clinical development program for a first-o

March 02, 11:10

Artilysin®: Promising Approach Against Acinetobacter baumannii Infected Wounds

Severe wound infections increasingly prove to be a serious medical challenge. Complications particularly arise from the high number of infections caused by resistant or multi-resistant pathogens. “

March 01, 14:30

Joe Kiani Provides Keynote at the 5th Annual Global Ministerial Summit on Patient Safety

In a keynote address at the Fifth Global Ministerial Summit on Patient Safety, Joe Kiani, founder of the Patient Safety Movement Foundation (PSMF), called for hospitals around the world to show greate

February 28, 13:30

Biocytogen’s Subsidiary Eucure Biopharma and Chipscreen Biosciences’ Holding Subsidiary Chipscreen NewWay Biosciences Enter into Greater China License Agreement for Bispecific Antibody YH008

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that its wholly owned subsidiary, Eucure (Beijing) Biopharma Co., Ltd. (“Eucure Biopharma”), has reached an e

February 24, 09:10

Merck Highlights New Four-Year Efficacy and Safety Data for Investigational BTK Inhibitor, Evobrutinib, in RMS

Not intended for UK and U.S. based media Merck, a leading science and technology company, today announced updated long-term efficacy and safety data for investigational evobrutinib that continue to

February 23, 13:35

LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits

LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment k

February 23, 11:15

Sinovac Amends Shareholder Rights Plan

Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder righ

February 23, 10:35

Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP)

Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron announce the signing of a licensing agreement in which Ferrer obtains the exclusive worldwide rights to

February 22, 11:50

Medidata Bolsters Senior Leadership Team to Further Accelerate the Digital Transformation of Life Sciences with Unmatched End-to-End Solutions

Medidata, a Dassault Systèmes company, today announced a new leadership structure designed to fuel its mission of creating end-to-end solutions that power smarter treatments and healthier people. The

February 22, 10:40

New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy

Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized controlled study published in Medicine in which Dr. Jin Hee Ahn and colleagues at the Sungkyunkwan Unive

News by Region

News by Industry